MLICM
KRMD icon

Metropolitan Life Insurance Company (MetLife)’s KORU Medical Systems KRMD Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio KRMD Stock Details KRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,939
Closed -$6.69K – 2421
2023
Q2 		$6.69K Buy
+1,939
New +$7.61K ﹤0.01% 2438
2020
Q3 		– Sell
-9,663
Closed -$86.8K – 2579
2020
Q2 		$86.8K Buy
+9,663
New +$97.7K ﹤0.01% 2340

Other funds holding KRMD

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s KRMD Position: Q3 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of KORU Medical Systems (KRMD) in Q3 2023, closing a stake of 1,939 shares — an estimated $6.69K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in KRMD in Q2 2020 and held it in 2 quarters. The position peaked at $86.8K in Q2 2020. 55 funds tracked by Wall St. Rank hold KRMD as of Q3 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining KORU Medical Systems position as of Q3 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,939 KORU Medical Systems shares in Q3 2023, an estimated $6.69K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in KORU Medical Systems in Q2 2020 and held it in 2 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s KORU Medical Systems position peaked at $86.8K in Q2 2020.
  • 55 funds tracked by Wall St. Rank held KORU Medical Systems as of Q3 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2023, filed 14 Nov 2023.